Role of transcriptional cofactors in nuclear receptor signalling transduction;Role des co-facteurs transcriptionnels dans la transduction des signaux hormonaux par les recepteurs nucleaires

Medecine/Sciences

Volumn 13, Issue 8-9, 1997, Pages 961-970

  Gelman, Laurent ^b   Staels, Bart ^b   Auwerx, Johan ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; DNA BINDING; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; SIGNAL TRANSDUCTION;

EID: 0030774374     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/493     Document Type: Article

References (47)

1. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark E, Chambon P. The nuclear receptor superfamily: the second decade. Cell 1995; 85: 835-9.
2. Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as basis for cell-and promoter-specific action of these hormones. Mol Endocrinol 1996; 10: 119-31.
3. Laudet V, Delannoy S. Comment mettre en route un récepteur nucléaire? Apport des données structurales. Med Sci 1996; 12: 528-32.
4. Cavaillès V. A la recherche des modulateurs de l'activité transcriptionnelle des récepteurs nucléaires. Med Sci 1996; 12: 229-33.
5. Oñate SA, Tsai SY, Tsai MJ, O'Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995; 270: 1354-7.
6. Yao TP, Ku G, Zhou N, Scully R, Livingston DM. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci USA 1996; 93: 10626-31.
7. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996; 85: 403-14.
8. Smith CL, Oñate SA, Tsai MJ, O'Malley BW. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci USA 1996; 93: 8884-8.
9. Voegel J, Heine MJS, Zechel C, Chambon P, Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 1996; 15: 3667-75.
10. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR. GR1P1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 1996; 93: 4948-52.
11. Vegeto E, Allan GF, Schrader WT, Tsai MJ, McDonnell DP, O'Malley BW. The mechanism of RU486 antagonism is dependent on the conformation of the carboxyterminal tail of the human progesterone receptor. Cell 1992; 69: 703-13.
12. Chrivia JC, Kwok RPS, Lamb N, Hagiwara M, Montminy MR, Goodman RH. Phosphorylated GREB binds specifically to the nuclear protein CBP. Nature 1993; 365: 855-9.
13. Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor, Genes Dev 1994; 8: 869-84.
14. Chakravarti D, LaMorte V, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM. Role of CBP/p300 in nuclear receptor signalling. Nature 1996; 383: 99-103.
15. Janknecht R, Hunter T. Transcriptional control: versatile molecular glue. Curr Biol 1996; 6: 951-4.
16. Yang XJ, Ogryzko VV, Nishikawa JI, Howard BH, Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 1996; 382: 319-24.
17. Eckner R, Ludlow JW, Lill NL, Oldread E, Arany Z, Modjtahedi N, DeCaprio JA, Livingston DM, Morgan JA. Association of p300 and CBP with simian virus 40 large T antigen. Mol Cell Biol 1996; 16: 3454-64.
18. Avantaggiati ML, Carbone M, Graessmann A, Nakatani Y, Howard B, Levine AS. The SV40 large T antigen and adenovirus E1A oncoproteins interact with dinstinct isoforms of the transcriptional coactivator p300. EMBO J 1996; 15: 2236-48.
19. Kitabayashi I, Eckner R, Arany Z, Chiu R, Gachelin G, Livingston DM, Yokoyama KK Phosphorylation of the adenovirus E1A-associated 300 kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells. EMBO J 1995; 14: 3496-509.
20. Eckner R, Yao TP, Oldread E, Livingston DM. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev 1996; 10: 2478-90.
21. Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RCM, Masuno M, Tommerup N, van Ommen GJB, Goodman RH, Peters DJM. Rubinstein-Taybi syndrome caused by mutations in the transcriptional coactivator CBP. Nature 1995; 376: 348-51.
22. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M. Estrogen receptor-associated proteins; possible mediators of hormone-induced transcription. Science 1994; 264: 1455-8.
23. Cavaillès V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 1995; 14: 3741-51.
24. Cavaillès V, Dauvois S, Danielian PS, Parker MG. Interaction of proteins with transcriptionally active estrogen receptor. Proc Natl Acad Sci USA 1994; 91: 10009-13.
25. Le Douarin B, Zechel C, Garnier JM, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R. The N-terminal part of T1F1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 1995; 14: 2020-33.
26. Lee JW, Choi HS, Gyurist J, Brent R, Moore DD. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Endocrinology 1995; 9: 243-54.
27. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 1995; 374: 91-4.
28. Vom Baur E, Zechel C, Heery D, Heine MJS, Garnier JM, Vivat V, Le Douarin B, Gronemeyer H, Chambon P, Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. Proc Natl Acad Sci USA 1996; 93: 5517-21.
29. Baniahmad C, Nawaz Z, Baniahmad A, Gleeson MAG, Tsai MJ, O'Malley BW. Enhancement of human estrogen receptor activity by SPT6: a potential coactivator Mol Endocrinol 1995; 9: 34-43.
30. McDonnell DP, Vegeto E, O'Malley BW. Identification of a negative regulatory function for steroid receptors. Proc Natl Acad Sci USA 1992; 89: 10563-7.
31. Yoshinaga SK, Peterson CL, Herskowitz I, Yamamoto KR. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 1992 258: 1598-603.
32. Muchardt C, Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J 1993; 12: 4279-90.
33. Okabe I, Bailey LC, Attree O, Srinivasan S, Perkel JM, Laurent BC, Carlson M, Nelson DL, Nussbaum RL. Cloning of human and bovine homologs of SNF2/SWI2: a global activator of transcription in yeast S. cerevisiae. Nucleic Acids Res 1996; 20: 4649-55.
34. Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 1993; 366: 170-4.
35. Chiba H, Muramatsu M, Nomoto A, Kato H. Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res 1994; 22: 1815-20.
36. Zeiner M, Gehring U. A protein that interacts with members of the nuclear hormone receptor family: identification and cDNA cloning. Proc Natl Acad Sci USA 1995; 92: 11465-9.
37. Seol W, Choi HS, Moore DD. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptor. Mol Endocrinol 1995; 9: 72-85.
38. 70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 1996; 93: 5517-21.
39. Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderström M, Glass CK. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995; 377: 397-404.
40. Kurokawa R, Söderström M, Hörlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 1995; 377: 451-4.
41. Kurokawa R, DiRenzo J, Boehm M, Sugarman J, Gloss B, Rosenfeld MG, Heyman RA, Glass CK. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 1994; 371: 528-31.
42. Vu-Dac N, Schoonjans K, Kosykh V, Dallongeville J, Heyman RA, Staels B, Auwerx J. Retinoids increase human apolipoprotein A-II expression through activation of the retinoid X receptor but not the retinoic acid receptor. Mol Cell Biol 1996; 16: 3350-60.
43. Don Chen J, Umesono K, Evans RM. SMRT isoforms mediate repression and anti-repression of nuclear receptors heterodimers. Proc Natl Acad Sci USA 1996; 93: 7567-71.
44. Don Chen J, Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995; 377: 454-7.
45. Burris TP, Nawaz Z, Tsai MJ, O'Malley BW. A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors. Proc Natl Acad Sci USA 1995; 92: 9525-9.
46. Burns K, Duggan B, Atkinson EA, Famulski KS, Nemer M, Bleackley RC, Michalak M. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 1994; 367: 476-80.
47. Dedhar S, Rennie PS, Shago M, Leung Hagesteijn CY, Hawley R, Bruchovsky N, Cheng H, Matusik RJ, Giguère V. Inhibition of nuclear hormone receptor activity by calreticulin. Nature 1994; 367: 480-3.